nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Alternative Treatments for Myelodysplastic Syndromes
|
Sekeres, Mikkael |
|
2005 |
42 |
S2 |
p. S32-S37 6 p. |
artikel |
2 |
Decitabine Dosing Schedules
|
Kantarjian, Hagop M. |
|
2005 |
42 |
S2 |
p. S17-S22 6 p. |
artikel |
3 |
Decitabine in Acute Myeloid Leukemia
|
Lübbert, Michael |
|
2005 |
42 |
S2 |
p. S38-S42 5 p. |
artikel |
4 |
Decitabine in Chronic Leukemias
|
Issa, Jean-Pierre J. |
|
2005 |
42 |
S2 |
p. S43-S49 7 p. |
artikel |
5 |
Decitabine in Myelodysplastic Syndromes
|
Saba, Hussain I. |
|
2005 |
42 |
S2 |
p. S23-S31 9 p. |
artikel |
6 |
Emerging Role of Epigenetic Therapy: Focus on Decitabine
|
Issa, Jean-Pierre J. |
|
2005 |
42 |
S2 |
p. S1-S2 2 p. |
artikel |
7 |
Future Directions for the Use of Hypomethylating Agents
|
Garcia-Manero, Guillermo |
|
2005 |
42 |
S2 |
p. S50-S59 10 p. |
artikel |
8 |
Masthead
|
|
|
2005 |
42 |
S2 |
p. CO2- 1 p. |
artikel |
9 |
Overview of Cancer Epigenetics
|
Jones, Peter A. |
|
2005 |
42 |
S2 |
p. S3-S8 6 p. |
artikel |
10 |
Pharmacology of 5-Aza-2′-deoxycytidine (decitabine)
|
Momparler, Richard L. |
|
2005 |
42 |
S2 |
p. S9-S16 8 p. |
artikel |
11 |
Supplement disclaimer
|
|
|
2005 |
42 |
S2 |
p. A2- 1 p. |
artikel |
12 |
Table of contents
|
|
|
2005 |
42 |
S2 |
p. A1- 1 p. |
artikel |